Related Experiment Videos
Fabrication of viable tissue-engineered constructs with 3D cell-assembly technique.
Yongnian Yan1, Xiaohong Wang, Yuqiong Pan
1Center of Organism Manufacturing, Department of Mechanical Engineering, Tsinghua University, Beijing 100084, PR China.
Biomaterials
|June 14, 2005
Summary
Scientists developed a novel organ manufacturing technique using precise 3D bioprinting. This method creates patterned cell/biomaterial structures with channels, supporting cell viability for artificial tissue and organ production.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Developing functional artificial human tissues and organs is a significant challenge in regenerative medicine.
- Existing methods often struggle to create complex, viable cellular architectures with integrated nutrient/waste transport systems.
Purpose of the Study:
- To introduce a new organ manufacturing technique for creating complex three-dimensional (3D) cell/biomaterial architectures.
- To demonstrate the capability of this technique in fabricating patterned structures with functional channels.
Main Methods:
- Utilized a highly accurate 3D micropositioning system with a pressure-controlled syringe.
- Employed a fine-bore exit needle for precise deposition of cell/biomaterial structures with 10-micrometer lateral resolution.
- Created various 3D patterns with arrays of channels (through-holes) for cell support.
Main Results:
- Successfully fabricated complex 3D cell/biomaterial architectures in designed patterns.
- Demonstrated that the created channels effectively supply nutrients and remove metabolites for embedded cells.
- Confirmed that embedded cells remain viable and functional within the 3D structures.
Conclusions:
- The developed organ manufacturing technique enables the precise fabrication of complex 3D cellular constructs.
- The integrated channel system supports long-term cell viability and biological function.
- This technology holds significant potential for the high-throughput production of artificial human tissues and organs.